Extended Anti-Clotting Therapy Cut Heart Attacks After Stent
CHICAGO, Nov 16 (Reuters) - Patients who took two anti-clotting drugs for 30 months after undergoing a heart stent placement significantly cut their risk of heart attacks and blood clots in the stent compared with patients receiving the dual therapy for the standard 12 months, a clinical trial showed.
In this five-year study of nearly 10,000 patients who had received drug-coated stents in an artery clearing procedure, the rate of heart attacks was 2.1 percent for those who received dual anti-clotting therapy for 30 months. The rate was 4.1 percent for those who got aspirin and a placebo after 12 months of dual therapy, researchers reported.
Help employers find you! Check out all the jobs and post your resume.
In this five-year study of nearly 10,000 patients who had received drug-coated stents in an artery clearing procedure, the rate of heart attacks was 2.1 percent for those who received dual anti-clotting therapy for 30 months. The rate was 4.1 percent for those who got aspirin and a placebo after 12 months of dual therapy, researchers reported.
Help employers find you! Check out all the jobs and post your resume.